PFBT
BIVV

Parkside Financial Bank & Trust’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Parkside Financial Bank & Trust’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-697
Closed -$37K – 1594
2017
Q4 		$37K Hold
697
– – 0.01% 430
2017
Q3 		$40K Buy
697
+672
+2,688% +$39.4K 0.02% 400
2017
Q2 		$1K Hold
25
– – ﹤0.01% 1361
2017
Q1 		$1K Buy
+25
New +$1.23K ﹤0.01% 1310

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Parkside Financial Bank & Trust's BIVV Position: Q1 2018 in Review

Parkside Financial Bank & Trust sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 697 shares — an estimated $37K sold.

Parkside Financial Bank & Trust first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $40K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Parkside Financial Bank & Trust reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 697 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $37K.
  • Parkside Financial Bank & Trust first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Parkside Financial Bank & Trust's Bioverativ Inc. Common Stock position peaked at $40K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2018, filed 2 May 2018.